A detailed history of Hantz Financial Services, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 44,514 shares of AZN stock, worth $2.93 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
44,514
Previous 44,112 0.91%
Holding current value
$2.93 Million
Previous $3.44 Million 0.81%
% of portfolio
0.06%
Previous 0.07%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$76.67 - $87.62 $30,821 - $35,223
402 Added 0.91%
44,514 $3.47 Million
Q2 2024

Jul 30, 2024

BUY
$66.81 - $80.83 $2.95 Million - $3.57 Million
44,112 New
44,112 $3.44 Million
Q1 2024

Aug 06, 2024

SELL
$61.03 - $69.57 $119,740 - $136,496
-1,962 Reduced 4.16%
45,238 $3.07 Million
Q4 2023

Aug 06, 2024

BUY
$61.89 - $69.28 $2.91 Million - $3.26 Million
46,986 Added 21956.07%
47,200 $3.18 Million
Q2 2023

Aug 06, 2024

SELL
$69.91 - $75.81 $11,744 - $12,736
-168 Reduced 43.98%
214 $15,000
Q1 2023

Aug 06, 2024

BUY
$63.15 - $71.6 $126 - $143
2 Added 0.53%
382 $27,000
Q4 2022

Aug 06, 2024

SELL
$54.21 - $70.44 $11,058 - $14,369
-204 Reduced 34.93%
380 $26,000
Q3 2022

Aug 06, 2024

BUY
$53.02 - $135.75 $7,793 - $19,955
147 Added 33.64%
584 $32,000
Q2 2022

Aug 06, 2024

SELL
$59.26 - $71.14 $592 - $711
-10 Reduced 2.24%
437 $29,000
Q1 2022

Aug 06, 2024

SELL
$55.72 - $67.12 $1,225 - $1,476
-22 Reduced 4.69%
447 $30,000
Q4 2021

Aug 06, 2024

SELL
$54.02 - $63.83 $1,026 - $1,212
-19 Reduced 3.89%
469 $27,000
Q3 2021

Aug 06, 2024

BUY
$55.56 - $60.79 $15,779 - $17,264
284 Added 139.22%
488 $29,000
Q1 2021

Aug 06, 2024

SELL
$47.16 - $54.44 $2.07 Million - $2.39 Million
-43,908 Reduced 99.54%
204 $10,000
Q3 2020

Aug 06, 2024

BUY
$53.07 - $61.1 $2,175 - $2,505
41 Added 20.1%
245 $13,000
Q2 2020

Aug 06, 2024

SELL
$43.1 - $55.31 $1.89 Million - $2.43 Million
-43,908 Reduced 99.54%
204 $11,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $204B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.